Management of HIV-related diarrhoea

International Journal of STD and AIDS

Volumn 8, Issue 5, 1997, Pages 286-297

  Neild, P J ^a   Nelson, M R ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Diarrhoea; Gastrointestinal infections; HIV

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; CISAPRIDE; CLARITHROMYCIN; CLINDAMYCIN; DIDANOSINE; ERYTHROMYCIN; FOSCARNET; GANCICLOVIR; LACTULOSE; LAXATINE; LETRAZURIL; METRONIDAZOLE; NELFINAVIR; PAROMOMYCIN; PENICILLIN G; RIFABUTIN; RITONAVIR; SAQUINAVIR; STAVUDINE; SULFAMETHOXAZOLE; TINIDAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; ZIDOVUDINE;

DIARRHEA; DRUG EFFECT; DRUG TOXICITY; GASTROINTESTINAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SENNA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; DIARRHEA; HUMANS;

EID: 0030908798     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971920109     Document Type: Review

References (71)

1. Connolly GM, Gazzard BG. Diarrhoea in human immunodeficiency virus (HIV) antibody positive patients. Gut 1988;29:703
2. Kotler DP, Reka S, Chow K, et al. Effects of enteric parasitoses and HIV infection upon small intestinal structure and function in patients with AIDS. J Clin Gastroenterol 1993;16:10-15
3. Miller ARO, Griffin GE, Batman P, et al. Jejunal mucosal architecture and fat malabsorption in male homosexuals infected with human immunodeficiency virus. Q J Med 1988;69:1009-19
4. Keating J, Bjarnason I, Somasundaram S, et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995;37:623-9
5. Kapembwa MS, Fleming SC, Griffin GE, et al. Fat absorption and exocrine pancreatic function in human immunodeficiency virus infection. Q J Med 1990;273:49
6. Sciaretta G, Bonazzi L, Monti M, et al. Bile acid malabsorption in AIDS-associated chronic diarrhoea: a prospective one-year study. Am J Gastroenterol 1994;89(3):379-81
7. Griffin GE, Miller A, Batman P, et al. Damage to jejunal intrinsic autonomic nerves in HIV infection. AIDS 1988;2:379-82
8. Batman PA, Miller AR, Sedgwick PM, Griffin GE. Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. AIDS 1991;5:1247-52
9. Belitsos PC, Greenson JK, Yardley JH, Sisler JR, Bartlett JG. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. J Infect Dis 1992;166:277-84
10. McGowan I, Radford-Smith G, Jewell DP. Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994;8:1569-75
11. Snijders F, van Deventer SLH, Bartelsman JFW, et al. Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal tissue. AIDS 1995;9:367-73
12. Demovitz JA, Pape JW, Boncy M, et al. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1986;315:87-90
13. Glaser JB, Morton-Klute L, Berger SR, et al. Recurrent Salmonella typhimurium bacteraemia associated with the acquired immunodeficiency syndrome. Ann Int Med 1985;102:189-93
14. Snijders F, Kuijper EJ, Danner SA, Dankert J. Uncommon campylobacters are not so uncommon in stool of HIV-infected patients. XI International Conference on AIDS 1996;1213(abstract)
15. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:1s-15s
16. Nelson MR, Shanson DC, Hawkins DA, Gazzard BG. Salmonella, campylobacter and shigella in HIV-positive patients. AIDS 1992;12:1495-8
17. Salmon D, Detruchis P, Leport C, et al. Efficacy of zidovudine in preventing relapses of Salmonella bacteraemia in AIDS. J Infect Dis 1991;163:415-16
18. Tumbarello M, Tacconelli E, Leone F, Cauda R, Ortona L. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. Eur J Gastroenterol Hepatol 1995;7:259-63
19. Barbut F, Mario N, Meyohas MC, Binet D, Frottier J, Petit JC. Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect 1994;26:181-9
20. Lu SS, Schwartz JM, Simon DM, Brandt LJ. Clostridium difficile-associated diarrhoea in patients with HIV positivity and AIDS: a prospective controlled study. Am J Gastroenterol 1994;89:1226-9
21. Surawicz CM, McFarland LV, Elmer G, Chinn J. Treatment of recurrent Clostridiiim difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989;84:1285-7
22. Buggy BP, Fekety R, Silva J Jr. Therapy of relapsing Clostridium dificile-associated diarrhoea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 1987;9:155-9
23. Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-8
24. Gray JR, Rabeneck L. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol 1989;84:1521-4
25. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteraemia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazamine, and ciprofloxacin. N Engl J Med 1996;335:377-83
26. Chave JP, Thorens J, Frohlich F, et al. Gastric and duodenal bacterial colonisation in HIV-infected patients without gastrointestinal symptoms. Am J Gastroenterol 1994;89: 2168-71
27. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994;35:23-6
28. Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996;348:379-83
29. Kotler DP, Orenstein JM. Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation. Am J Gastroenterol 1994;89: 1998-2002
30. Desportes I, Le Charpentier Y, Galian A, et al. Occurrence of a new microsporidian; Enterocytozon bieneusi n.g., n.sp., in the enterocytes of a human patient with AIDS. J Protozool 1985;32:250-4
31. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhoea. Ann Int Med 1991;114:366-72
32. Pol S, Romana CA, Richard S, et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 1993;328:95-9
33. Orenstein JM, Dieterich DT, Kotler DP. Systemic dissemination by a newly recognised intestinal microsporidia species in AIDS. AIDS 1992;6:1143-50
34. Curry A. Emerging pathogens-microsporidia and the acquired immunodeficiency syndrome. PHLS Microbiol Digest 1996;13(2):76-80
35. Sandfort J, Hannemann A, Gelderblom H, Stark K, Owen RL, Ruf B. Enterocytozoon bieneusi infection in an immunocompetent patient who had acute diarrhoea and who was not infected with the immunodeficiency virus. Clin Infect Dis 1994;19:514-16
36. Sobottka I, Albrecht H, Schottelius J, et al. Self-limited travellers diarrhoea due to a dual infection with Enterocytozoon bieneusi and Cryptosporidium parvum in an immunocompetent HIV-negative child. Eur J Clin Microbiol Infect Dis 1995;14:919-20
37. Kotler DP, Giang TT, Garro ML, Orenstein JM. Light microscopic diagnosis of microsporidiosis in patients with AIDS. Am J Gastroenterol 1994;89:540-4
38. Dore GJ, Marriott DJ, Hing MC, Harkness JL, Field AS. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole Clin Infect Dis 1995;21:70-6
39. Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis 1994;169:178-83
40. Sharpstone D, Rowbottom A, Nelson M, Gazzard B. Thalidomide for microsporidiosis. AIDS 1995;9:658-9 (letter)
41. Anwar-Bruni DM, Hogan SE, Schwartz DN, Wilcox CM, Bryan RT, Lennox JL. Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1 infected patients. AIDS 1996;10:619-23
42. Blanshard C, Jackson AM, Shanson DC, Francis N, Gazzard BG. Cryptosporidiosis in HIV-seropositive patients. Q J Med 1992;85:813-23
43. White AC Jr, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Goodgame RW. Paromomycin for cryptosporidiosis in AIDS: a prospective double-blind trial. J Infect Dis 1994;170419-24
44. Harris M, Deutsch G, Maclean JD, Tsoukas CM. A phase 1 study of letrazuril in AIDS-related cryptosporidiosis. AIDS 1994;8:1109-13
45. Nord J, Ma P, Dijohn D, et al. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhoea in AIDS patients. AIDS 1990;4:581
46. Chandrasekar PH. 'Cure' of chronic cryptosporidiosis during treatment with azidothymidine in a patient with the acquired immunodeficiency syndrome. Am J Med 1987;83:187
47. Laughon BE, Druckman DA, Vernon A, et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988;94:984-92
48. Pape JW, Verdier RI, Johnson WD Jr. Treatment and prophylaxis of Isopora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989;320:1044-7
49. Nelson MR, Connolly GM, Hawkins DA, Gazzard BG. Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome. Am J Gastroenterol 1992;86:876-81
50. Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acq Imm Defic Syndr 1991;4:s29-35
51. Wu GD, Shintaku IP, Chien K, Geller SA. A comparison of routine light microscopy, immunohistochemistry, and in situ hybridisation for the detection of cytomegalovirus in gastrointestinal biopsies. Am J Gastroenterol 1989;84: 1517-20
52. Blanshard C, Benhamou Y, Dohin E, Lernstedt JO, Gazzard BG. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomised comparison. J Infect Dis 1995;172:622-8
53. Dieterich DT, Poles MA, Dicker M. Tepper R, Lew E. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am J Gastroenterol 1993;88:542-8
54. Kaljot KT, Ling JP, Gold JW, et al. Prevalence of acute enteric viral pathogens in acquired immunodeficiency syndrome patients with diarrhoea. Gastroenterology 1989; 97:1031-2
55. Grohmann GS, Glass RI, Pereira HG, et al. Enteric viruses and diarrhoea in HIV-infected patients. Enteric opportunistic infections working group (review). N Engl J Med 1993;329:14-20
56. Maggi P, Brandonisio O, Larocca AM, et al. Cyclospora in AIDS patients: not always an agent of diarrhoeic syndrome. New Microbiol 1995;18:73-6
57. Durepaire N, Ranger-Rogez S, Gandji JA, Weinbreck P, Rogez JP, Denis F. Enteric prevalence of adenovirus in human immunodeficiency virus seropositive patients. J Med Virol 1995;45:56-60
58. Janoff EN, Orenstein JM, Manischewitz JF, Smith PD. Adenovirus colitis in the acquired immunodeficiency syndrome. Gastroenterology 1991;100:976-9
59. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990;69:361-74
60. McKinsey DS, Gupta MR, Riddler SA, et al. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Int Med 1989;111:655-9
61. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 1995;98:336-42
62. Ullrich R, Heise W, Bergs C, L'Age M, Riecken EO, Zeitz M. Effects of zidovudine treatment of the small intestinal mucosa in patients infected with the human immunodeficiency virus. Gastroenterology 1992;102:1483-92
63. McCullough JB, Batman PA, Miller ARO, Sedgwick PM, Griffin GE. Depletion of neuroendocrine cells in rectal biopsy specimens from HIV-positive patients. J Clin Pathol 1992;15:524-7
64. Genta RM, Chappell CL, White Jr AC, Kimball KT, Goodgame RW. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 1993;105:1769-75
65. Blanshard C, Gazzard BG. Natural history and prognosis of diarrhoea of unknown cause in patients with acquired immunodeficiency syndrome (AIDS). Gut 1995;36:283-6
66. Blanshard C, Gazzard BG. An algorithm for the investigation of diarrhoea in HIV infection. Gut 1991;32: A1225 (abstract)
67. Goodgame RW, Kimball K, Ou C-N, et al. Intestinal function and injury in acquired immunodeficiency syndrome related cryptosporidiosis. Gastroenterology 1995;108: 1075-82
68. Manfredi R, Vezzadini P, Costigliola P, Ricchi E, Fanti MP. Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea: effects of treatment with octreotide. AIDS 1993;7:223-6
69. Simon DM, Cello JP, Valenzuela J, et al. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhoea. Gastroenterology 1995;108:1753-60
70. Sharpstone D, Rowbottom A, Lepper M, Nelson M, Gazzard B. Faecal tumour necrosis factor-alpha in HIV-related diarrhoea. AIDS (in press)
71. Bjarnason I, Sharpstone DR, Francis N, et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 1996;10:1385-91